Developing and Commercializing Innovative Vaccines
Protecting The World Against Infectious Diseases
Utilizing Proven Innovative Adjuvant Technology
Dynavax is a commercial stage biopharmaceutical company committed to developing and commercializing novel vaccines to help protect the world against infectious diseases, by utilizing proven, innovative adjuvant technology.
Our vision and work ethic are guided by the collective ideals underpinning Our Values, and these form the basis of our company culture.
Recent News
May 05, 2022